source
- Frontier Medicines CEO vows to accelerate cancer drug pipeline after recent layoffsFrontier Medicines announced that after a restructuring that included layoffs last year, the company is refocusing on its AI-driven proteomics platform to push more cancer therapies into clinical t…
- Biotech IPOs approach ‘escape velocity’ barring yellow flags that could threaten reboundTwenty-five biotechs have used the IPO route to go public this year—with five of those debuts occurring this month alone. It’s the most IPOs since 2021, when the industry recorded 78 during the hei…